Novo Nordisk announced on 24 November 2025 the end of its phase 3 EVOKE and EVOKE+ trials, which investigated oral semaglutide – the active ingredient in Rybelsus, approved for type 2 diabetes – as a potential treatment... (Audio Available – 365 words – 2 minute read time)
A large genetic study suggests that popular cholesterol lowering drugs like statins could help ward off dementia by reducing harmful fat build up in blood vessels. Researchers found that people with natural gene changes that keep cholesterol levels low... (Audio Available – 575 words – 3 minute read time)
At the European Academy of Neurology Congress in Helsinki, researchers unveiled a ground breaking blood test that could revolutionize Alzheimer’s disease management by identifying
Two innovative Alzheimer’s drugs, Donanemab and Lecanemab, have been rejected by the NHS due to their exorbitant cost and limited impact. These are the first treatments to slow the disease, potentially extending